Phosphodiesterase type 5 inhibitor (sildenafil) – impact in proliferative diabetic retinopathy?
Abstract
Acta OphthalmologicaEarly View Letter to the Editor Phosphodiesterase type 5 inhibitor (sildenafil) – impact in proliferative diabetic retinopathy? Ani Korhonen, Ani Korhonen orcid.org/0000-0002-6864-4596 Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, FinlandSearch for more papers by this authorErika Gucciardo, Erika Gucciardo orcid.org/0000-0003-4481-8798 Individualized Drug Therapy Research...
Paper Details
Title
Phosphodiesterase type 5 inhibitor (sildenafil) – impact in proliferative diabetic retinopathy?
Published Date
Nov 8, 2021
Journal
Volume
100
Issue
5
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History